| editorial | Q871232 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041680904 |
| P356 | DOI | 10.1007/S00508-009-1165-Z |
| P698 | PubMed publication ID | 19562277 |
| P2093 | author name string | Friedrich Thaiss | |
| P2860 | cites work | ABO-incompatible living donor transplantation: is it economically "compatible"? | Q79955721 |
| [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions] | Q79979170 | ||
| [The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection] | Q79979192 | ||
| Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies | Q80241621 | ||
| Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations | Q80318166 | ||
| ABO antigen expression in graft tissue: is titration against donor erythrocytes relevant? | Q80418533 | ||
| Present techniques for antibody removal | Q80418538 | ||
| Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab | Q80418543 | ||
| [Immunosorption (IAS) "matures"] | Q81221985 | ||
| Antibody-mediated rejection in renal allografts: lessons from pathology | Q36910391 | ||
| ABO incompatible kidney transplantation | Q37035918 | ||
| B cells and tertiary lymphoid organs in renal inflammation | Q37038382 | ||
| C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts | Q37042154 | ||
| New approaches of B-cell-directed therapy: beyond rituximab | Q37128305 | ||
| The critical role of plasmapheresis in ABO-incompatible renal transplantation | Q37227538 | ||
| Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantation | Q40132083 | ||
| Vienna experience of ABO-incompatible living-donor kidney transplantation | Q43982164 | ||
| Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors | Q46100656 | ||
| Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection | Q46913121 | ||
| Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. | Q54586327 | ||
| Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation | Q79897615 | ||
| Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation | Q79955710 | ||
| P433 | issue | 7-8 | |
| P304 | page(s) | 227-229 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Vienna Clinical Weekly | Q15759796 |
| P1476 | title | ABO-incompatible kidney transplantation | |
| P478 | volume | 121 |
Search more.